FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Fresenius Warns Against Mobile Device Reg Overlap

[ Price : $8.95]

Fresenius Medical asks FDA and other agencies to ensure that there is no regulatory overlap or unintended consequences in regulati...

FDA Clears Royal Phillips Ultrasound

[ Price : $8.95]

FDA clears a Royal Philips Electronics 510(k) for the EPIQ ultrasound system.

Info on Submitting Info to CVM with e-Submission Gateway

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on submitting information in electronic format to CVM us...

Guidance on Non-Clinical Testing for Intravascular Stents

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance: Select Updates for Non-Clinical Engineering Tests and Recommended Labeling...

FDA Nixes Expanded Indication on Otsukas Tolvaptan

[ Price : $8.95]

FDA sends Otsuka a complete response letter on its NDA for tolvaptan for an expanded indication in treating adult patients with ra...

FDA Gives Cepheid TB Test Moderate Complexity Designation

[ Price : $8.95]

FDA categorizes Cepheids Xpert MTB/RIF test as moderate complexity under the Clinical Laboratory Improvement Amendments (CLIA).

FDA Makes Priority Reviews More Restrictive: PhRMA

[ Price : $8.95]

PhRMA says FDA has made qualifying criteria for drug and biologic makers to obtain a priority review designation more restrictive.

Courts Questioning False Claims Act Implied Certification

[ Price : $8.95]

Attorneys Brian Dunphy and Ellyn Sternfield say federal judges are beginning to question whether to permit False Claims Act suits ...

FDA Needs Modern Regulatory Approach for Innovation: White Paper

[ Price : $8.95]

An Epstein Becker & Green white paper says FDA should update its regulatory system to accommodate the new reality of e-health.

Cubist Recalls 4 Cubicin Lots

[ Price : $8.95]

Cubist Pharmaceuticals recalls four lots of Cubicin (daptomycin for injection) due to the presence of particulate matter in some v...